Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun 22;40(6):537-545.
doi: 10.1093/stmcls/sxac022.

Systems for the Functional Evaluation of Human Heart Tissues Derived from Pluripotent Stem Cells

Affiliations
Review

Systems for the Functional Evaluation of Human Heart Tissues Derived from Pluripotent Stem Cells

Kozue Murata et al. Stem Cells. .

Abstract

Human pluripotent stem cells (hPSCs) are expected to be a promising cell source in regenerative medicine and drug discovery for the treatment of various intractable diseases. An approach for creating a 3-dimensional (3D) structure from hPSCs that mimics human cardiac tissue functions has made it theoretically possible to conduct drug discovery and cardiotoxicity tests by assessing pharmacological responses in human cardiac tissues by a screening system using a compound library. The myocardium functions as a tissue composed of organized vascular networks, supporting stromal cells and cardiac muscle cells. Considering this, the reconstruction of tissue structure by various cells of cardiovascular lineages, such as vascular cells and cardiac muscle cells, is desirable for the ideal conformation of hPSC-derived cardiac tissues. Heart-on-a-chip, an organ-on-a-chip system to evaluate the physiological pump function of 3D cardiac tissues might hold promise in medical researchs such as drug discovery and regenerative medicine. Here, we review various modalities to evaluate the function of human stem cell-derived cardiac tissues and introduce heart-on-a-chip systems that can recapitulate physiological parameters of hPSC-derived cardiac tissues.

Keywords: cardiomyocyte; cardiotoxicity; organ-on-a-chip; pluripotent stem cell.

PubMed Disclaimer

Figures

Graphical Abstract
Graphical Abstract
Figure 1.
Figure 1.
In vitro evaluation methods for cardiotoxicity in the human heart. Abbreviations: hPSCs, human pluripotent stem cells; hPSC-CMs, cardiomyocytes induced from hPSCs; CMs, cardiomyocytes; ECs, vascular endothelial cells; MCs, vascular mural cells; 2D, 2-dimensional; 3D, three-dimensional.
Figure 2.
Figure 2.
The application of heart-on-a-chip systems in drug discovery research and regenerative medicine. Abbreviations: 3D hPSC-CMs, three-dimensional cardiomyocytes induced from human pluripotent stem cells; 2D hPSC-CMs, 2-dimensional cardiomyocytes induced from human pluripotent stem cells.

Similar articles

Cited by

References

    1. Virani SS, Alonso A, Benjamin EJ, et al. . Heart disease and stroke statistics—2020 update: a report from the American Heart Association. Circulation. 2020; 141(9):e139-e596 - PubMed
    1. Mangini S, Alves BR, Silvestre OM, et al. . Heart transplantation: review. Einstein (Sao Paulo). 2015;13:310-318. 10.1590/S1679-45082015RW3154. - DOI - PMC - PubMed
    1. Packer M, Bristow MR, Cohn JN, et al. . The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355. 10.1056/NEJM199605233342101. - DOI - PubMed
    1. Lechat P. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet. 1999;353:9-131. - PubMed
    1. Lian X, Hsiao C, Wilson G, et al. . Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc Natl Acad Sci USA. 2012;109:E1848-E1857. - PMC - PubMed